Peter Vozzo | IR, Westwicke |
Jack Khattar | President and CEO |
Greg Patrick | Chief Financial Officer |
David Amsellem | Piper Sandler |
David Steinberg | Jefferies |
Annabel Samimy | Stifel Nicolaus |
Good morning, and welcome to the Supernus Pharmaceuticals Second Quarter 2020 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to Peter Vozzo of Westwicke, Investor Relations representative of Supernus Pharmaceuticals, you may begin.
Thank you, Sarah. Good morning, everyone, and thank you for joining us today for Supernus Pharmaceuticals' second quarter 2020 financial results conference call.